Gary Patou's Net Worth
$14.3 Million
Estimate Recalculated Jul 3, 2024 05:55PM EST
Who is Gary Patou?
Gary Patou has an estimated net worth of $14.3 Million. This is based on reported shares across multiple companies, which include Xenon Pharmaceuticals Inc., Pacira Pharmaceuticals, Inc., and OSCIENT PHARMACEUTICALS CORP.
SEC CIK
Gary Patou's CIK is 0001283535
Past Insider Trading and Trends
2005 was Gary Patou's most active year for acquiring shares with 39 total transactions. Gary Patou's most active month to acquire stocks was the month of May. 2005 was Gary Patou's most active year for disposing of shares, totalling 86 transactions. Gary Patou's most active month to dispose stocks was the month of November. 2014 saw Gary Patou paying a total of $510,888.48 for 105,504 shares, this is the most they've acquired in one year. In 2014 Gary Patou cashed out on 159,700 shares for a total of $6,819,438.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $47.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4/A
| -60.78% | -7.60K |
$41.05 | -$311,897.90 | 4.9K |
Dec 14
| |||
Form 4
| -21.06% | -7.60K |
$24.88 | -$741,408.54 | 28.48K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| -8.03% | -2.06K |
$18.61 | -$136,611.61 | 23.57K |
Nov 23 - Nov 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4/A
|
∞
| 2.54K |
$13.63 | -$3,817.78 | 2.54K |
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira Pharmaceuticals, Inc. (PCRX) Snapshot price: $28.71
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$55.21 | -$1,801,942.36 |
0
|
Scheduled
|
Aug 7
| ||
Form 4
| +14.24% | 300 |
$46.86 | -$2,388,631.53 | 2.41K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
$39.09 | -$2,117,976.32 |
0
|
Scheduled
|
May 9 - May 12
| ||
Form 4
| +254.55% | 504 |
—
|
—
| 702 |
Mar 11
| |||
Form 4
| +72.17% | 83 |
—
|
—
| 198 |
Nov 18
| |||
Form 4
|
—
|
0
|
$25.27 | -$946,200.00 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$15.53 | -$1,113,100.00 |
0
|
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
|
—
|
0
|
$15.81 | -$283,900.00 |
0
|
Scheduled
|
Apr 12
| ||
Form 4
|
—
|
0
|
$14.88 | -$796,291.00 |
0
|
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OSCIENT PHARMACEUTICALS CORP No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.17% | 300 |
—
|
—
| 14.14K |
Jun 12
| |||
Form 4
| +2.22% | 300 |
—
|
—
| 13.84K |
Jun 7
| |||
Form 4
| +2.27% | 2.4K |
—
|
—
| 108.33K |
Jun 8
| |||
Form 4
| -15.88% | -20.00K |
$1.26 | -$25,200.00 | 105.93K |
Scheduled
|
May 31
| ||
Form 4
| -19.24% | -30.00K |
$1.33 | -$39,900.00 | 125.93K |
Scheduled
|
May 22
| ||
Form 4
| -24.28% | -50.00K |
$1.73 | -$86,500.00 | 155.93K |
Scheduled
|
Apr 25 - Apr 26
| ||
Form 4
| -4.63% | -10.00K |
$1.98 | -$19,800.00 | 205.93K |
Scheduled
|
Mar 30
| ||
Form 4
| -12.20% | -30.00K |
$2.11 | -$63,300.00 | 215.93K |
Scheduled
|
Mar 20 - Mar 21
| ||
Form 4
| -3.91% | -10.00K |
$2.10 | -$21,000.00 | 245.93K |
Scheduled
|
Mar 3
| ||
Form 4
| -3.76% | -10.00K |
$1.93 | -$19,300.00 | 255.93K |
Scheduled
|
Feb 27
| ||
Form 4
| -5.34% | -15.00K |
$2.10 | -$31,500.00 | 265.93K |
Scheduled
|
Feb 10
| ||
Form 4
| -8.17% | -25.00K |
$2.29 | -$57,250.00 | 280.93K |
Scheduled
|
Feb 7
| ||
Form 4
| -3.17% | -10.00K |
$2.15 | -$21,500.00 | 305.93K |
Scheduled
|
Jan 27
| ||
Form 4
| -3.07% | -10.00K |
$2.50 | -$25,000.00 | 315.93K |
Scheduled
|
Jan 12
| ||
Form 4
| -8.66% | -30.92K |
$2.50 | -$77,157.92 | 325.93K |
Scheduled
|
Jan 9
| ||
Form 4
| -3.77% | -15.00K |
$2.28 | -$34,200.00 | 382.86K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$1.04 | -$24,345.02 | 790.71K |
Scheduled
|
Nov 28 - Nov 29
| ||
Form 4
|
—
|
0
|
$1.02 | -$37,768.00 | 392.86K |
Scheduled
|
Nov 17 - Nov 18
| ||
Form 4
|
—
|
0
|
$0.93 | -$25,800.00 | 392.86K |
Scheduled
|
Oct 31
| ||
Form 4
|
—
|
0
|
$1.00 | -$27,700.00 | 392.86K |
Scheduled
|
Oct 25
| ||
Form 4
|
—
|
0
|
$1.00 | -$37,000.00 | 392.86K |
Scheduled
|
Oct 20
| ||
Form 4
|
—
|
0
|
$1.11 | -$31,150.00 | 392.86K |
Scheduled
|
Sep 29 - Sep 30
| ||
Form 4
|
—
|
0
|
$1.10 | -$30,930.00 | 392.86K |
Scheduled
|
Sep 27
| ||
Form 4
|
—
|
0
|
$1.31 | -$49,400.00 | 392.86K |
Scheduled
|
Sep 6
| ||
Form 4
|
—
|
0
|
$1.15 | -$42,900.00 | 377.86K |
Scheduled
|
Aug 29 - Aug 30
| ||
Form 4
| +2.65% | 10K |
$1.35 | -$8,460.00 | 377.86K |
Scheduled
|
Aug 25 - Aug 26
| ||
Form 4
|
—
|
0
|
$1.44 | -$15,015.00 | 377.86K |
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
$1.44 | -$27,300.00 | 377.86K |
Scheduled
|
Aug 3
| ||
Form 4
| +0.74% | 2.78K |
$1.40 | -$66,405.54 | 377.86K |
Scheduled
|
Jul 21
| ||
Form 4
| +0.15% | 556 |
$1.34 | -$12,611.08 | 375.08K |
Scheduled
|
Jul 14
| ||
Form 4
| +0.60% | 2.22K |
$1.35 | -$51,044.46 | 374.52K |
Scheduled
|
Jul 8
| ||
Form 4
| +0.75% | 2.78K |
$1.33 | -$62,555.54 | 372.3K |
Scheduled
|
Jun 22
| ||
Form 4
| +0.61% | 2.22K |
$1.55 | -$27,618.66 | 369.52K |
Scheduled
|
Jun 20 - Jun 21
| ||
Form 4
| +1.07% | 3.89K |
$1.54 | -$20,610.98 | 367.3K |
Scheduled
|
Jun 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| -0.14% | -500.00 |
$2.05 | -$1,025.00 | 363.41K |
Scheduled
|
Apr 26
| ||
Form 4
| +0.78% | 2.78K |
$1.17 | -$54,705.54 | 357.46K |
Scheduled
|
Mar 30 - Mar 31
| ||
Form 4
| +0.79% | 2.78K |
$1.13 | -$52,795.47 | 354.68K |
Scheduled
|
Mar 28 - Mar 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +1.21% | 4.44K |
$1.55 | -$118,088.92 | 371.9K |
Scheduled
|
Feb 24 - Feb 25
| ||
Form 4
| +0.30% | 1.11K |
$1.54 | -$29,222.23 | 367.46K |
Scheduled
|
Feb 17
| ||
Form 4
| +0.65% | 2.22K |
$1.65 | -$63,044.46 | 346.35K |
Scheduled
|
Jan 31
| ||
Form 4
| +100.18% | 172.22K |
$1.68 | -$52,044.46 | 344.13K |
Scheduled
|
Jan 25 - Jan 26
| ||
Form 4
| +1.66% | 2.81K |
$1.89 | -$36,103.02 | 171.9K |
Scheduled
|
Jan 7
| ||
Form 4
| +49.34% | 89.16K |
$2.09 | -$22,240.66 | 269.86K |
Scheduled
|
Dec 30
| ||
Form 4
| +10.91% | 15.48K |
$1.81 | -$189,916.61 | 157.3K |
Scheduled
|
Dec 27 - Dec 29
| ||
Form 4
| +53.67% | 22.51K |
$2.38 | -$164,637.02 | 64.45K |
Scheduled
|
Dec 3
| ||
Form 4
| +242.28% | 29.69K |
$1.86 | -$349,383.37 | 41.94K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
| -8.52% | -1.14K |
$1.57 | -$1,794.87 | 12.25K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Sep 2 - Sep 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Aug 24 - Aug 25
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||